6 Dimensions Capital

Total investments

48

Average round size

68M

Portfolio companies

37

Rounds per year

6.86

Lead investments

14

Follow on index

0.17

Exits

12

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

Considering the real fund results, this VC is 38 percentage points more often commits exit comparing to other organizations. The fund is generally included in 7-12 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2018. The higher amount of exits for fund were in 2019. This 6 Dimensions Capital works on 16 percentage points less the average amount of lead investments comparing to the other organizations.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the 6 Dimensions Capital, startups are often financed by ARCH Venture Partners, WuXi Healthcare Ventures, Venrock. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Hillhouse Capital Group, Boyu Capital. In the next rounds fund is usually obtained by Temasek Holdings, Yonghua Capital, Windham Venture Partners.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline GRAIL, CStone Pharmaceuticals, Yiyao The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Pharmaceutical, Medical Device.

We also calculated 3 valuable employees in our database.

Show more

Investments analytics

Analytics

Total investments
48
Lead investments
14
Exits
12
Rounds per year
6.86
Follow on index
0.17
Investments by industry
  • Biotechnology (32)
  • Health Care (30)
  • Pharmaceutical (18)
  • Medical (16)
  • Therapeutics (9)
  • Show 17 more
Investments by region
  • United States (24)
  • China (19)
  • Israel (2)
Peak activity year
2018
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
383M
Group Appearance index
0.85
Avg. company exit year
5
Avg. multiplicator
4.21
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Deltafour 01 Apr 2023 Analytics, Artificial Intelligence, Service Industry Seed Bangalore, Karnataka, India
MitrAssist 26 Sep 2023 Biotechnology, Health Diagnostics, Pharmaceutical Late Stage Venture 100M HaMerkaz, Misgav Dov, Israel
WiseTek 06 Aug 2018 Health Care, Medical Device, Video, Electronics Seed 463K Zhejiang, Yinzhou District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.